Visby Medical

San Jose, CA · Founded 2012 · Privately Held (backing)

Developer of polymerase chain reaction (PCR) based diagnostic testing devices designed for the detection of infectious diseases. Visby Medical is based in San Jose, CA and was founded in 2012. Its last reported valuation was $866 million in May 2020. It has raised $487 million across 1 recorded round; the latest was a $109 million later-stage round in Feb 2022.

Last reported valuation
$866.0M
Oct 2026
Priced at
—
Total raised
$486.6M
Last round
Later Stage VC
Feb 2022
How much has Visby Medical raised?
$486.6Macross 1 recorded rounds · Feb 2022 – Feb 2022

Most recently, Visby Medical raised $108.6M in its Later Stage VC (Feb 2022).

Free account
More of Visby Medical with a free account
  • ·The complete investor list: 35 names
  • ·Watch Visby Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Visby Medical round by round

1 rounds
Feb 2022Later Stage VC$108.6MSEC filing▮
45 investors participated

How much has Visby Medical raised?

Visby Medical has raised $487 million in total; 1 of its rounds is on record. The largest on record was a $109 million later-stage round in Feb 2022.

Visby Medical has filed 1 Form D with the SEC, most recently in Mar 2022 ($109 million sold to 45 investors).

Visby Medical investors

35 investors are on record for Visby Medical, including Plug and Play Tech Center, National Institutes of Health, Amplify Partners and Catalio Capital Management. By type, the record holds 7 venture capital firms and 1 hedge fund. The later-stage round in Feb 2022 drew 45 investors.

For fundraisers
Raising for a company like Visby Medical?

35 investors have backed Visby Medical.

See all 35 investors →

Frequently asked about Visby Medical

How much has Visby Medical raised?
Visby Medical has raised $486.6M in total across 1 recorded funding rounds.
When was Visby Medical's last funding round?
Visby Medical's most recent recorded round was Later Stage VC in Feb 2022, raising $108.6M.